Clinical Trial Update: Reappraisal of GIK in Acute STEMI by Pre-hospital Administration [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating pre-hospital administration of glucose-insulin-potassium (GIK) in acute ST-elevation myocardial infarction (STEMI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-elevation Myocardial Infarction

Drugs mentioned

• Glucose-insulin-potassium (GIK) solution (glucose-insulin-potassium)

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Myocardial Infarction | Phase 3 | Status: UNKNOWN